Member Detail - DF/HCC

Dr. Steven Isakoff, MD, PhD

Claim this profile

Massachusetts General Hospital Cancer Center

Studies Breast Cancer
Studies Triple-Negative Breast Carcinoma
7 reported clinical trials
13 drugs studied

Area of expertise

1Breast Cancer
Steven Isakoff, MD, PhD has run 7 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
HER2 negative
ER negative
2Triple-Negative Breast Carcinoma
Steven Isakoff, MD, PhD has run 2 trials for Triple-Negative Breast Carcinoma. Some of their research focus areas include:
Stage IV
Stage I
Stage II

Affiliated Hospitals

Image of trial facility.
Massachusetts General Hospital Cancer Center
Image of trial facility.
Massachusetts General Hospital

Clinical Trials Steven Isakoff, MD, PhD is currently running

More about Steven Isakoff, MD, PhD

Clinical Trial Related8 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Steven Isakoff, MD, PhD has experience with
  • Dostarlimab
  • Niraparib
  • Pembrolizumab
  • PVX-410
  • Radiation Therapy
  • DBT-TOBI

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Steven Isakoff, MD, PhD specialize in?
Steven Isakoff, MD, PhD focuses on Breast Cancer and Triple-Negative Breast Carcinoma. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 negative.
Is Steven Isakoff, MD, PhD currently recruiting for clinical trials?
Yes, Steven Isakoff, MD, PhD is currently recruiting for 1 clinical trial in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Steven Isakoff, MD, PhD has studied deeply?
Yes, Steven Isakoff, MD, PhD has studied treatments such as Dostarlimab, Niraparib, Pembrolizumab.
What is the best way to schedule an appointment with Steven Isakoff, MD, PhD?
Apply for one of the trials that Steven Isakoff, MD, PhD is conducting.
What is the office address of Steven Isakoff, MD, PhD?
The office of Steven Isakoff, MD, PhD is located at: Massachusetts General Hospital Cancer Center, Boston, Massachusetts 02215 United States. This is the address for their practice at the Massachusetts General Hospital Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security